PGE1 is administered via continuous intravenous infusion. The initial dosing typically ranges from 0.05 to 0.1 micrograms per kilogram per minute. The dose may be adjusted based on the clinical response and side effects. The infusion is usually started as soon as the diagnosis is suspected and continued until surgical intervention can be performed.